APA (7th ed.) Citation

Y, B., D, D., P, S., M, B., V, V., JC, G., . . . JL, G. (2026). Leptin antagonism improves Rett syndrome phenotype in symptomatic Mecp2-deficient mice. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 23(3), e00910. https://doi.org/10.1016/j.neurot.2026.e00910

Chicago Style (17th ed.) Citation

Y, Belaïdouni, et al. "Leptin Antagonism Improves Rett Syndrome Phenotype in Symptomatic Mecp2-deficient Mice." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 23, no. 3 (2026): e00910. https://doi.org/10.1016/j.neurot.2026.e00910.

MLA (9th ed.) Citation

Y, Belaïdouni, et al. "Leptin Antagonism Improves Rett Syndrome Phenotype in Symptomatic Mecp2-deficient Mice." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 23, no. 3, 2026, p. e00910, https://doi.org/10.1016/j.neurot.2026.e00910.